REVIEWS |
|
T.Yu. Semiglazova (1, 2), I.V. Sorokina (3)
Prognostic and predictive values of the PIK3CA gene mutation in patients with breast cancer
|
10-20 |
|
A.E. Zhukova, S.A. Protsenko, A.V. Novik, D.O. Yurlov
Prognostic markers for testicular germ cell tumors. Research perspectives
|
21-26 |
|
I.A. Baldueva (1), A.V. Novik (1, 2)
The role of peripheral blood immunological parameters as predictive markers in cancer patients: the prognostic role of the neutrophil/lymphocyte ratio
|
28-32 |
ORIGINAL ARTICLES |
|
N.N. Buevich (1), S.A. Protsenko (1), A.K. Nosov (1), S.A. Reva (1, 2), A.S. Artemyeva (1), M.V. Berkut (1)
Intermediate assessment of the results of a clinical study of a neoadjuvant combined treatment of patients with high-risk and very high-risk prostate cancer
|
33-37 |
|
N.P. Belyak (1, 2), S.I. Kutukova (1, 3), R.V. Orlova (1, 2), N.V. Zhukova (1, 2), S.P. Erdniev (1), E.Yu. Zorina (1), I.V. Avramenko (1), N.Yu. Antimonik (1), N.V. Popova (1), A.K. Ivanova (1), A.V. Androsova (1)
The use of ramukirumab in the treatment of metastatic gastric cancer in real clinical practice
|
38-42 |
|
E.V. Bakhidze (1, 2), V.A. Belyaeva (3), A.A. Domansky (1), N.A. Mikaya (1), I.V. Berlev (1, 2)
Pharmacotherapy and surgical treatment of adult granulosa cell ovarian tumors: analysis of own and literature data
|
43-49 |
|
P.V. Kazantseva (1), E.M. Slonimskaya (1, 2), M.M. Tsyganov (1), M.K. Ibragimova (1, 3), A.V. Doroshenko (1), N.A. Tarabanovskaya (1), N.V. Litviakov (1, 3)
Predictive and prognostic significance of stemness gene amplifications in the breast tumor in patients who received neoadjuvant chemotherapy
|
50-56 |
|
L.Yu. Vladimirova, I.L. Popova, N.A. Abramova, A.E. Storozhakova, N.M. Tikhanovskaya, K.A. Novoselova, A.A. Lyanova, L.A. Ryadinskaya, M.O. Yezhova, M.A. Teplyakov
Trastuzumab emtanzin in the treatment of HER2-positive metastatic breast cancer in patients with visceral crisis
|
58-63 |
|
|
L.V. Filatova (1, 2)
Immunotherapy for classic Hodgkin’s lymphoma
|
64-72 |
|
S.A. Protsenko (1), A.I. Semenova (1), A.P. Oganesyan (1), E.M. Anokhina (1), A.V. Novik (1, 2)
Modern immunotherapy for kidney cancer
|
73-78 |
|
K.O. Kondratieva, M.V. Vagaytseva, T.Yu. Semiglazova
The role of the medical psychologist in the multidisciplinary team for the rehabilitation of cancer patients
|
79-81 |
|
V.S. Fomin, V.N. Yakovenko
Resonance electrostimulation in the treatment of postoperative motor-evacuation disorders: theoretical rationale and therapeutic algorithm of application
|
82-87 |
|
N.V. Zhukova (1, 2), R.V. Orlova (1, 2), N.Yu. Antimonik (1), S.I. Kutukova (1, 3), N.P. Belyak (1, 2), O.V. Vasyusina (3), N.V. Popova (1)
The effectiveness of an integrated approach to the treatment of patients with melanoma with metastatic brain lessions: clinical observation
|
88-95 |
|
D.D. Sakaeva (1, 2), A.F. Nasretdinov (1)
Oral chemotherapy with vinorelbine for advanced breast cancer: its role in clinical practice
|
96-101 |
|
S.A. Protsenko, G.M. Teletaeva, E.A. Degtiareva, E.V. Levchenko, N.E. Levchenko, A.V. Mishchenko, I.A. Burovik, A.S. Artemyeva, E.N. Imyanitov, A.I. Semenova, A.V. Novik, D.Kh. Latipova
PEComas: what are the treatment options? literature review and personal experience
|
102-107 |
Русский
